Reuters logo
BRIEF-Novaliq's NovaTears treatment for evaporative dry eye disease launches in New Zealand and receives registrational approval in Australia
October 30, 2017 / 12:30 PM / 22 days ago

BRIEF-Novaliq's NovaTears treatment for evaporative dry eye disease launches in New Zealand and receives registrational approval in Australia

Oct 30 (Reuters) - Novaliq:

* Novaliq’s NovaTears® treatment for evaporative dry eye disease launches in New Zealand and receives registrational approval in Australia Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below